3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Brain Neoplasms
2
Radiation Injuries
1
Prostatic Neoplasms
1
Popliteal Cyst
1
Pneumonia
1
Optic Neuritis
1
Myelitis, Transverse
1
Myelitis
1
Myasthenia Gravis
1
Glioma
1
Breast Neoplasms
1
Arthritis, Rheumatoid
1
Interventions
Radiotherapy
8
Cisplatin
3
Carboplatin
3
sargramostim
2
Radiotherapy, Intensity-Modulated
2
Paclitaxel
2
Donepezil
2
cevimeline
1
beta Carotene
1
alpha-Tocopherol
1
Zinc Sulfate
1
Vortioxetine
1
Vitamin E
1
Standard of Care
1
Sodium Chloride
1
Salts
1
Radiotherapy, Conformal
1
Radiosurgery
1
Oxygen
1
Oxaliplatin
1
Neck Dissection
1
Mometasone Furoate
1
Meditation
1
Hyperbaric Oxygenation
1
Glutamine
1
G(M1) Ganglioside
1
Filgrastim
1
Fibroblast Growth Factor 7
1
Etoposide
1
Erythropoietin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Radiation Injuries
×
Adrenal Cortex Hormones
×
Clear all
NCT06888817
2026-02-25
BRAINS
The Netherlands Cancer Institute
Phase 3
Recruiting
408 enrolled